|
|
BSE |
NSE |
|
|
Products & Services > Company Profile > Profit & Loss |
|
| Procter & Gamble Health Ltd | Industry : Pharmaceuticals - Multinational | BSE Code: | 500126 | | NSE Symbol: | PGHL | | P/E : | 34.97 | ISIN Demat: | INE199A01012 | | Div & Yield %: | 1.29 | | EPS : | 136.54 | Book Value: | 485.4698795 | | Market Cap (Rs.Cr): | 7925.5 | | Face Value : | 10 | |
|
(Rs. In Crores) |
|
| | | | | | Sales Turnover | 1229.62 | 1114.41 | 1008.73 | 1355.86 | 848.99 | 711.47 | Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.34 | Net Sales | 1229.62 | 1114.41 | 1008.73 | 1355.86 | 848.99 | 698.13 | Other Income | 18.39 | 13.19 | 18.10 | 68.89 | 767.93 | 73.94 | Stock Adjustments | -2.85 | 4.75 | -1.73 | 13.03 | 3.47 | -13.99 | Total Income | 1245.16 | 1132.35 | 1025.10 | 1437.78 | 1620.39 | 758.08 | | | | | | | Raw Materials | 358.99 | 344.55 | 310.39 | 444.47 | 272.83 | 222.95 | Power & Fuel Cost | 12.88 | 14.70 | 12.97 | 19.09 | 12.23 | 11.68 | Employee Cost | 206.17 | 167.56 | 153.66 | 182.93 | 131.27 | 109.88 | Other Manufacturing Expenses | 90.86 | 98.43 | 90.82 | 136.56 | 89.75 | 53.65 | Selling & Administrative Expenses | 196.86 | 203.91 | 173.99 | 257.28 | 192.98 | 188.49 | Miscellaneous Expenses | 36.33 | 22.33 | 19.15 | 13.15 | 5.25 | 20.52 | Less : Pre-operative Expenses Capitalised | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Total Expenditure | 902.09 | 851.48 | 760.98 | 1053.48 | 704.31 | 607.17 | Operating Profit | 343.07 | 280.87 | 264.12 | 384.30 | 916.08 | 150.91 | Interest | 0.77 | 0.42 | 0.80 | 0.00 | 0.00 | 0.00 | Gross Profit | 342.30 | 280.45 | 263.32 | 384.30 | 916.08 | 150.91 | Depreciation | 28.10 | 27.08 | 30.04 | 29.45 | 21.12 | 19.12 | Profit Before Tax | 314.20 | 253.37 | 233.28 | 354.85 | 894.96 | 131.79 | Tax | 89.79 | 60.81 | 63.60 | 94.78 | 50.22 | 44.54 | Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Deferred Tax | -5.06 | 0.04 | -7.12 | 5.99 | 6.02 | -6.66 | Reported Net Profit | 229.47 | 192.52 | 176.80 | 254.08 | 838.72 | 93.91 | Extraordinary Items | 0.51 | -0.40 | -0.31 | -2.25 | 6.11 | 11.59 | Adjusted Net Profit | 228.96 | 192.92 | 177.11 | 256.33 | 832.61 | 82.32 | Adjustment below Net Profit | -1.84 | 0.70 | 0.42 | -159.42 | -6.97 | -6.21 | P & L Balance brought forward | 237.07 | 327.70 | 532.26 | 1167.97 | 361.12 | 291.68 | Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Appropriations | 93.79 | 283.85 | 381.78 | 730.37 | 24.90 | 18.26 | P & L Balance carried down | 370.91 | 237.07 | 327.70 | 532.26 | 1167.97 | 361.12 | Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.90 | Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Equity Dividend % | 615.00 | 525.00 | 1300.00 | 2300.00 | 4400.00 | 150.00 | Dividend Per Share(Rs) | 61.50 | 52.50 | 130.00 | 230.00 | 440.00 | 15.00 | Earnings Per Share-Unit Curr | 138.23 | 115.98 | 106.51 | 102.04 | 505.25 | 56.57 | Earnings Per Share(Adj)-Unit Curr | 138.23 | 115.98 | 106.51 | 102.04 | 505.25 | 56.57 | Book Value-Unit Curr | 452.34 | 371.38 | 423.92 | 545.99 | 927.78 | 441.72 | Book Value(Adj)-Unit Curr | 452.34 | 371.38 | 423.92 | 545.99 | 927.78 | 441.72 |
|
|
|
|
|
|